SecBot SecBot
6-K ·Filed Sep 2, 2026

ACB

AURORA CANNABIS INC
BULLISH
Impact 7/10
Horizonweeks Processed1mo ago SEC0001279569-26-000846
Notable filing: 6-K
Actionable Insight ▲ Bullish

The hostile bid creates near-term volatility. Traders should monitor for a possible higher bid or competing offer. Shareholder rejection likely; defensive measures may include a shareholder rights plan or pursuit of alternative transactions.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d
ACB ▼ -3.23% at T+20d
LONG call ✗ call lost -3.23% · α vs SPY -2.90% · entry $4.03 → $3.90
Next anchor: T+60d in 4w
Latest observation: T+36 -13.11% FF3 residual α
Entry = T+0 close
Sep 2, 2026
via day close
T+1d
-3.47%
call -3.47% · α -4.52%
$3.89
settled 8w ago
T+5d
-7.44%
call -7.44% · α -6.49%
$3.73
settled 7w ago
T+20d
-3.23%
call -3.23% · α -2.90%
$3.90
settled 27d ago
T+60d
Pending
in 4w

Price Chart

Loading chart...

Executive Summary

Aurora Cannabis filed a 6-K urging shareholders to reject Curaleaf's hostile takeover bid, arguing it is inadequate and undervalues the company. Aurora's board is unanimously recommending shareholders take no action and not tender their shares.

Key Facts

  • Aurora's board unanimously recommends shareholders reject Curaleaf's hostile bid
  • Aurora is debt-free with $149 million in cash
  • Curaleaf carries over $1 billion in debt
  • Aurora shareholders would own ~7.7% of combined entity but only ~3.2% of votes
  • Aurora received a fairness opinion from its financial advisor on September 1, 2026
  • TD Securities analyst commented the bid undervalues Aurora
  • Special Committee of independent directors reviewed and recommended rejection

Financial Impact

Aurora has $149 million cash, is debt-free; Curaleaf has over $1 billion in debt

cash positiondebtvoting powershareholder value

Risk Factors

  • Hostile bid may still succeed if shareholders tender or if Curaleaf raises its offer
  • Aurora shareholders face dilution and voting power loss if bid succeeds
  • Curaleaf's debt load and lack of US exchange listing add risk to consideration received

Market Snapshot

Exchange
Nasdaq
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
60% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001279569-26-000846
Document: aurora_6k.htm0001279569-26-000846
Document: 0001279569-26-000846-index-headers.html0001279569-26-000846
Document: 0001279569-26-000846-index.html0001279569-26-000846
Document: 0001279569-26-000846.txt0001279569-26-000846
29 reports for ACB
Performance horizon
57% Hit rate @ T+5 4 of 7 directional calls Went positive at some point 5 of 7 best @ T+5▲ +3.26%Apr 15, 2026
Filters
Rows
Reports for ACB — sortable, filterable
TypeNow
Oct 26, 2026
1d ago
6-K
NEUTRAL ★ 4/10
$3.90awaiting T+5—$4.15 (+6.41%)
Oct 14, 2026
13d ago
6-K
NEUTRAL ★ 6/10
$4.10 $3.97▼ −3.17%▼ −2.16%$4.15 (+1.22%)
Oct 8, 2026
19d ago
6-K
NEUTRAL ★ 4/10
$4.43 $4.10▼ −7.45%▼ −7.17%$4.15 (−6.32%)
Oct 6, 2026
21d ago
6-K
NEUTRAL ★ 6/10
$4.46 $4.17▼ −6.50%▼ −5.52%$4.15 (−6.95%)
Oct 5, 2026
22d ago
6-K
NEUTRAL ★ 5/10
$4.59 $4.29▼ −6.54%▼ −6.40%$4.15 (−9.59%)
Sep 16, 2026
5w ago
6-K
NEUTRAL ★ 4/10
$3.83 $4.22▲ +10.18%▲ +7.62%$4.15 (+8.36%)
Sep 14, 2026
6w ago
6-K
NEUTRAL ★ 5/10
$3.81 $4.03▲ +5.77%▲ +5.67%$4.15 (+8.92%)
Sep 9, 2026
6w ago
6-K
NEUTRAL ★ 3/10
$3.88 $3.83▼ −1.29%▼ −0.63%$4.15 (+6.96%)
Sep 2, 2026
7w ago
6-K
BULLISH ★ 7/10
$4.03 $3.73▼ −7.44%▼ −6.49%$4.15 (+2.98%)
Aug 24, 2026
9w ago
6-K
NEUTRAL ★ 5/10
$3.94 $4.05▲ +2.79%▲ +2.32%$4.15 (+5.33%)
Showing 10 of 29

US Market Status

Market Closed — Opens Thu (9h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 2, 2026